Sydney. Kirby Institute 2024.
The Annual Surveillance Report has been published each year since 1997. The report provides a comprehensive analysis of HIV, viral hepatitis and sexually transmissible infections in Australia.
London, Elsevier 2025.
Hepatitis C (HCV) testing innovations such as dried blood spot (DBS) and point-of-care testing should have fewer client-related barriers than traditional diagnostic pathways, yet there is limited evidence on their acceptability among people who inject drugs. This study sought to evaluate the acceptability testing modalities among people at risk of HCV infection and understand the circumstances in which such testing is most preferred.
Doylestown PA, Hepatitis B Foundation 2025.
Provides information about the major risk factors for liver cancer - hepatitis B and hepatitis C. Outlines additional risk factors including cirrhosis, excessive alcohol use and smoking, as well as obesity and diabetes.
London, Springer Nature 2025.
The implementation of national vaccination programs has demonstrated significant success in reducing HBV seroprevalence among pregnant women, which is particularly evident in the substantial decrease in HBsAg seroprevalence in Taiwan post-July 1986.
Harm Reduction Journal ; Vol. 21, Issue 1. London, Springer Nature 2024.
Alcohol and other drug and primary care services for people who use drugs should adopt person-centred approaches and recognise the gradual nature of behavioural change to foster empathy and supportive relationships to promote engagement in HCV care. Additionally, integrating HCV treatment with mobile outreach services and providing practical assistance, such as housing and financial incentives, are critical to ensuring that individuals remain engaged in HCV care.
Melbourne, Liver Foundation 2025.
Information about substances that are harmful to the liver including alcohol and drugs, herbs, supplements and chemicals.
Geneva, World Health Organization 2025. Available in Arabic, Chinese, English, French, Russian and Spanish.
Fact sheet on sodium reduction: key facts, overview, recommendations, actions and WHO response.
Hep C U Later (NHS), England, 2024. 4p. Blog post.
“It’s clear that people affected by homelessness are faced with multiple barriers and issues. Our role in this is to provide people with the support they need.”
Adelaide, Hepatitis SA 2024.
This three-day event brought together AIVL Member Organisations, Affiliate Members, partners, and allies to engage in presentations, workshops, and panel discussions focused on the health and human rights of people who use drugs.
London, Springer Nature 2024.
The principles identified in this study can be used as a guide for checking-in on progress with clients and may be considered as a model for reflection on practice by staff providing similar peer-led services.
Melbourne, LiverWELL (Hepatitis Victoria) 2025.
Talks about prevalence, prevention strategies, the risks associated with hepatitis B, and how to work together to combat the stigma that often surrounds it.
Melbourne, LiverWELL (Hepatitis Victoria) 2024.
Intended as a general guide to visa resources relating to hepatitis B.
Perth, Aust Indigenous HealthInfoNet 2024.
Examines the epidemiology, prevention, and management of blood-borne viruses experienced by ATSI peoples in Australia.
Melbourne, Sydney, The Conversation 2025.
Research shows 37 new prisons have been built in Australia since 2000, largely influenced by contracts with private profit-making prison providers. But the evidence shows increased incarceration doesn’t help reduce crime.
Zurich. Int Network on Hepatitis in Substance Users (INHSU) 2024.
Provides guidance across three core areas: Advocacy planning; hepatitis C information and education; prison-based hepatitis C care advocacy. For those new to advocacy, or experienced.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.